<DOC>
	<DOC>NCT00754039</DOC>
	<brief_summary>The primary objective of this study is to compare the effect of Welchol in combination with TriCor compared to TriCor alone on low-density lipoprotein cholesterol (LDL-C) in patients with high cholesterol.</brief_summary>
	<brief_title>Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hyperlipidemia, Familial Combined</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>3070 years of age History of mixed hyperlipidemia Prescribed a Step 1 diet at least 30 days prior to screening Women were not pregnant, breastfeeding, or plan to become pregnant during the study Women had a hysterectomy or tubal ligation, were postmenopausal, or practiced reliable birth control procedures Serum LDLC &gt;/= 115 mg/dL; Serum TG &gt;/= 150 &amp; &lt; 750 mg/dL BMI &gt;40 HbA1C &gt; 10% Type 1 diabetes Intolerance to fibrates History of intolerance to colesevelam HCl History of swallowing disorders or intestinal motility disorders Any other disorder that might interfere with the conduct of the study History of drug or alcohol abuse Recent (within 28 days) history of cardiac disease (MI, CHF, CABG, etc.)</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Mixed hyperlipidemia</keyword>
</DOC>